FDA product code GIT: Reagent & Control, Partial Thromboplastin Time

GIT is the FDA product code for reagent & control, partial thromboplastin time. It is a Class II device, regulated under 21 CFR 864.7925 and reviewed by the Hematology panel. FDA has cleared 4 510(k) submissions under GIT, from 4 different applicants. The average 510(k) review took 52 days (median 42).

Classification

FieldValue
Device nameReagent & Control, Partial Thromboplastin Time
Device classClass II
Regulation21 CFR 864.7925
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every GIT clearance

Top GIT applicants

ApplicantClearancesLatest
Biotrack, Inc.11989-02-23
Organon Teknika Corp.11988-08-17
Creative Laboratory Products, Inc.11988-03-18
Pacific Hemostasis11982-03-26

Most recent GIT clearances

510(k)ApplicantDeviceDecision dateReview days
K890051Biotrack, Inc.BIOTRACK APTT CONTROLS1989-02-2348
K881999Organon Teknika Corp.PLATELIN(R) EXCEL L1988-08-1797
K880711Creative Laboratory Products, Inc.CLP 0.02 M CALCIUM CHLORIDE SOLUTION.1988-03-1825
K820450Pacific HemostasisTHROMBOSCREEN1982-03-2636

Recalls for GIT devices

FDA recall records list no recalls for product code GIT.

Frequently asked questions

What is FDA product code GIT?

GIT is the FDA product code for reagent & control, partial thromboplastin time. It is a Class II device, regulated under 21 CFR 864.7925 and reviewed by the Hematology panel.

What device class is GIT?

Class II, regulation 21 CFR 864.7925. Typical premarket route: 510(k).

How long does a 510(k) take for product code GIT?

Across 4 cleared submissions the average was 52 days from receipt to decision (median 42).

Which companies have the most GIT clearances?

Biotrack, Inc. (1); Organon Teknika Corp. (1); Creative Laboratory Products, Inc. (1); Pacific Hemostasis (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times